Aster DM Healthcare


Aster DM Healthcare Limited is an Indian healthcare company founded by Azad Moopen in 1987. The company is registered in Bengaluru, which became the headquarters for its India operations following the separation of its Gulf Cooperation Council business in 2024. Aster operates a network of hospitals, clinics, pharmacies, and diagnostic centres across several Indian states.

History

Aster DM Healthcare was established by Azad Moopen in 1987 as a single-doctor clinic. The organisation gradually expanded through hospitals, clinics, pharmacies, diagnostics, and training institutions. Its formal presence in India began in 2001 with the Malabar Institute of Medical Sciences in Kozhikode, Kerala, which was later integrated into the Aster network.
In 2014, the company opened Aster Medcity in Kochi. In 2016, it acquired Kavery Medical Institute in Bengaluru, redeveloping it as Aster CMI Hospital. The same year, it took over the DM Wayanad Institute of Medical Sciences and acquired a majority stake in Dr. Ramesh Hospitals in Andhra Pradesh. In 2018, Aster added Sangamitra Hospitals to its network and launched an initial public offering, with shares subsequently listed on Indian stock exchanges.
New facilities established in the following years included Aster MIMS Kannur and Aster RV Hospital in Bengaluru in 2019. In 2021, the company opened a hospital in Kottakkal focused on women and children, followed by Aster Whitefield in Bengaluru in 2023.
In November 2023, Aster DM Healthcare announced a plan to separate its GCC and India businesses. The demerger was approved in January 2024. In April 2024, a consortium led by Fajr Capital acquired a 65% stake in Aster GCC, while the Moopen family retained 35% and operational control. Within India, the Moopen family continued to hold a 41.88% stake in Aster DM Healthcare. The company's subsidiary, Affinity Holdings, received 907.6 million from the transaction.
In November 2024, Aster announced a merger with Quality Care India Ltd., to form Aster DM Quality Care Ltd.
In 2025, the company opened a 100-bed hospital in Sharjah and a 264-bed Aster MIMS hospital in Kasaragod, Kerala. It increased its stake in Dr. Ramesh Cardiac and Multispecialty Hospital Private Limited to 70.49%.

Investors

In 2012, Olympus Capital Holdings Asia acquired a minority stake in Aster DM Healthcare for about 100 million, becoming the company’s largest external investor. In May 2014, Olympus invested an additional 60 million. Olympus exited its investment in June 2024. Following the GCC–India separation, the Moopen family continues to hold 41.88% of the Indian business.

Subsidiaries

Aster DM Healthcare operates through multiple subsidiaries and affiliates, including 9 subsidiaries, 67 step-down subsidiaries, and 4 associate companies. Notable operations include:Aster Medcity, Kochi, Kerala: Opened in 2015, this hospital is located on a 40-acre campus in Kochi, Kerala. At present, it is a 1745 bed quaternary care healthcare centre in a 40-acre campus.Aster Pharmacy: Established in 1989, it operates a network of pharmacies across India.Aster Labs: Formerly known as Aster Diagnostic Centre, this division provides diagnostic services and operates a laboratory in Bengaluru, along with 20 satellite laboratories and over 190 patient service centres across several Indian states. It offers a range of medical tests.Dr. Moopen’s Medical College, Wayanad, Kerala: A medical college in Wayanad offering undergraduate and postgraduate programs in medicine, nursing, and pharmacy.Aster Health Academy: An initiative for healthcare education and professional training.

Community initiatives

Aster Guardians Global Nursing Award

The Aster Guardians Global Nursing Award was established in 2022 to recognize nurses in areas such as patient care, leadership, education, community service, and healthcare innovation. The first award was presented in Dubai in May 2022 to Anna Qabale Duba of Kenya. The second edition took place in London in May 2023, with Margaret Helen Shepherd from the United Kingdom receiving the award. The third edition was held in Bengaluru in November 2024, with over 78,000 applicants from more than 200 countries. Winners are selected by an independent jury, with Ernst & Young LLP serving as the external evaluation partner.